Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Tsoi

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Bioanalysis|March 14, 2014
A practical approach to automate randomized design of experiments for ligand-binding assaysJennifer Tsoi, Vimal Patel, Judy Shih
Health Promotion Practice|March 1, 2014
On your time: online training for the public health workforceHope Worden Kenefick, Sharon Ravid, Kathleen MacVarish, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 24, 2009
Applications of a planar electrochemiluminescence platform to support regulated studies of macromolecules: benefits and limitations in assay rangeTheingi Thway, Chris Macaraeg, Dominador Calamba, et al.
Bioanalysis|July 5, 2013
Laboratory automation of high-quality and efficient ligand-binding assays for biotherapeutic drug developmentJin Wang, Vimal Patel, Daniel Burns, et al.
BMC Cancer|May 6, 2015
Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibitionStephen Mok, Jennifer Tsoi, Richard C Koya, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 12, 2010
A strategy for improving comparability across sites for ligand binding assays measuring therapeutic proteinsChad A Ray, Lei Zhou, Jennifer Tsoi, et al.
Scientific Reports|June 9, 2016
CRAF R391W is a melanoma driver oncogeneMohammad Atefi, Bjoern Titz, Jennifer Tsoi, et al.
Journal of Translational Medicine|April 7, 2019
Interleukin 32 expression in human melanomaHelicia Paz, Jennifer Tsoi, Anusha Kalbasi, et al.
Science Translational Medicine|March 20, 2015
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanomaSiwen Hu-Lieskovan, Stephen Mok, Blanca Homet Moreno, et al.
Cancer Discovery|June 15, 2018
Immunotherapy Resistance by Inflammation-Induced DedifferentiationArnav Mehta, Yeon Joo Kim, Lidia Robert, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Bioanalysis|March 14, 2014
A practical approach to automate randomized design of experiments for ligand-binding assaysJennifer Tsoi, Vimal Patel, Judy Shih
Health Promotion Practice|March 1, 2014
On your time: online training for the public health workforceHope Worden Kenefick, Sharon Ravid, Kathleen MacVarish, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 24, 2009
Applications of a planar electrochemiluminescence platform to support regulated studies of macromolecules: benefits and limitations in assay rangeTheingi Thway, Chris Macaraeg, Dominador Calamba, et al.
Bioanalysis|July 5, 2013
Laboratory automation of high-quality and efficient ligand-binding assays for biotherapeutic drug developmentJin Wang, Vimal Patel, Daniel Burns, et al.
BMC Cancer|May 6, 2015
Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibitionStephen Mok, Jennifer Tsoi, Richard C Koya, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 12, 2010
A strategy for improving comparability across sites for ligand binding assays measuring therapeutic proteinsChad A Ray, Lei Zhou, Jennifer Tsoi, et al.
Scientific Reports|June 9, 2016
CRAF R391W is a melanoma driver oncogeneMohammad Atefi, Bjoern Titz, Jennifer Tsoi, et al.
Journal of Translational Medicine|April 7, 2019
Interleukin 32 expression in human melanomaHelicia Paz, Jennifer Tsoi, Anusha Kalbasi, et al.
Science Translational Medicine|March 20, 2015
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanomaSiwen Hu-Lieskovan, Stephen Mok, Blanca Homet Moreno, et al.
Cancer Discovery|June 15, 2018
Immunotherapy Resistance by Inflammation-Induced DedifferentiationArnav Mehta, Yeon Joo Kim, Lidia Robert, et al.
Pageof 4